Main Authors: | Sanja Stanisic, Americo Cicchetti, Camillo Porta, Giuseppe Procopio, Patrizia Berto |
---|---|
Format: | Article |
Language: | English |
Published: |
AboutScience Srl
2018-07-01
|
Series: | Global & Regional Health Technology Assessment |
Online Access: | https://journals.aboutscience.eu/index.php/grhta/article/view/434 |
Similar Items
-
Costo-Efficacia di cabozantinib nel trattamento di seconda linea del tumore a cellule renali metastatico (mRCC) in Italia
by: Sanja Stanisic, et al.
Published: (2018-07-01) -
by: Sanja Stanisic, et al.
Published: (2019-04-01) -
The cost-effectiveness of alemtuzumab in the management of relapse-remitting multiple sclerosis in Italy
by: Sanja Stanisic, et al.
Published: (2019-04-01) -
Impact of SARS-CoV-2 on Provided Healthcare. Evidence From the Emergency Phase in Italy
by: Rossella Di Bidino, et al.
Published: (2020-11-01) -
Second-line treatment in renal cell carcinoma: clinical experience and decision making
by: Valentina Guadalupi, et al.
Published: (2021-06-01)